AVR 2.33% $14.65 anteris technologies ltd

2:1000000 million chance of getting brain damage from Herpes, page-67

  1. 13,929 Posts.
    lightbulb Created with Sketch. 128
    I think GSK had a stab at a herpes vaccine a few years ago. They hit a brick wall at the Phase 3 trial phase. A GSK like Big Pharma will be needed to fund late stage trials.

    Will be interesting to see if authorities include a future preventative herpes vaccine on the immunization schedule. It will need to satisfy a number of requirements including whether the vaccination is a priority. Apart from neonate herpes, herpes doesnt damage any vital organs and doesnt lead to death in people so, in a world of tight health budgets and competing health priorities, it may not be considered a huge priority.

    I personally believe because it has relatively minor morbidity issues I reckon the health authorities might be inclined to wait until they have years (maybe decades) of data behind it before its put on a universal vaccination schedule. It doesnt prevent people from getting a vax in the meantime, they just have to pay for it from their own pocket.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$14.65
Change
-0.350(2.33%)
Mkt cap ! $309.6M
Open High Low Value Volume
$14.50 $14.94 $14.25 $1.266M 86.85K

Buyers (Bids)

No. Vol. Price($)
2 126 $14.25
 

Sellers (Offers)

Price($) Vol. No.
$14.65 99 1
View Market Depth
Last trade - 16.10pm 05/08/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.